Qualigen Therapeutics, Inc.
QLGN
$5.23
-$0.36-6.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 179.36% | -67.60% | 192.33% | -81.28% | -91.15% |
| Total Receivables | -- | -- | -- | 451.44% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -33.49% | 11.43% | 95.97% | -45.03% | -67.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -83.73% | -- | -- | -- |
| Total Current Assets | 641.15% | 183.64% | 301.48% | -32.95% | -89.01% |
|
|
|||||
| Total Current Assets | 641.15% | 183.64% | 301.48% | -32.95% | -89.01% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -99.77% | -- | -- |
| Total Assets | 641.52% | 183.84% | 130.50% | -46.41% | -95.94% |
|
|
|||||
| Total Accounts Payable | -24.24% | -15.02% | -29.46% | 4.24% | 5.56% |
| Total Accrued Expenses | -59.14% | -74.23% | -69.12% | -55.33% | -53.29% |
| Short-term Debt | 116.57% | -17.53% | -- | 72.36% | -6.05% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -40.44% | -74.03% | 323.94% | -64.31% | -86.76% |
| Total Other Current Liabilities | -40.44% | -74.03% | 323.94% | -64.31% | -86.76% |
| Total Current Liabilities | 16.68% | -37.80% | -51.47% | -25.23% | -43.34% |
|
|
|||||
| Total Current Liabilities | 16.68% | -37.80% | -51.47% | -25.23% | -43.34% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 116.57% | -17.53% | -- | 72.36% | -6.05% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 16.68% | -37.80% | -51.47% | -25.23% | -51.10% |
|
|
|||||
| Common Stock & APIC | 5.87% | 6.59% | 4.64% | 6.52% | 3.14% |
| Retained Earnings | -5.80% | -5.78% | -5.36% | -6.87% | -8.78% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.84% | 20.78% | -44.39% | -30.49% | -310.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.84% | 20.78% | -44.39% | -30.49% | -310.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 61.38% | 100.94% | 227.35% | -30.49% | -229.32% |
|
|
|||||